Table 3 Pharmacy perspectives of codeine as a popular product or problem and cross-country comparisons
Ireland (n = 464) (n, %) | South Africa (n = 123) (n, %) | UK (n = 129) (n, %) | Test statistic χ2(df) | p-value | |
|---|---|---|---|---|---|
Most popular product | |||||
Cough/cold syrup | 8 (1.8%) | 34 (27.9%) | 1 (0.8%) | 122.7 (2) | < 0.001* |
Combination medication | 448 (98.2%) | 88 (72.1%) | 128 (99.2%) | ||
Missing | 10 | 1 | 0 | ||
Codeine as significant health problem | 302 (65.1%) | 91 (74.0%) | 75 (58.1%) | 7.6 (2) | 0.02* |
Amount of codeine misused | |||||
Low | 177 (38.2%) | 40 (32.5%) | 59 (45.7%) | ||
Medium | 204 (44.9%) | 56 (46.3%) | 59 (45.7%) | ||
High | 73 (16.1%) | 25 (20.7%) | 10 (7.8%) | ||
Missing | 12 | 2 | 1 | 2.9 | 0.09 |